Sensus Healthcare to Participate in Two Upcoming Investor Conferences

BOCA RATON, Fla., Aug. 27, 2018

Annual B. Riley FBR Healthcare Conference
Date:	Tuesday, September 4, 2018
Format:	One-on-one meetings only
Venue: ARIVA.DE Börsen-Geflüster Kurse Sensus Healthcare, Inc. Common Stock -   0,00%	New York Marriott East Side in New York City
H.C. Wainwright 20th Annual Global Investment Conference
Date:	September 4-6, 2018
Format:	Company presentation
Presentation:	Thursday, September 6, 2018 at 11:40 a.m. Eastern time
Venue:	St. Regis New York Hotel in New York City

Mr. Sardano's presentation at the H.C. Wainwright 20^th Annual Global Investment Conference will be webcast live and available for replay in the Investor Relations section of the Company's website at sensushealthcare.com. 

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit http://www.sensushealthcare.com.

Contact:
LHA Investor Relations 
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com

View original content:http://www.prnewswire.com/news-releases/sensus-healthcare-to-participate-in-two-upcoming-investor-conferences-300702054.html

SOURCE Sensus Healthcare